Gefitinib drug Edit

«Gefitinib (ZD1839) (INN, /ɡɛˈfɪtɪnɪb/, trade name Iressa)[1] is a drug used for certain breast, lung and other cancer. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cell. Therefore, it is only effective in cancer with mutated and overactive EGFR. It is marketed by AstraZeneca and Teva.» (wikipedia)

  • Has Subnodes:

Modified 3 weeks ago on Dec 28, 2019
MoreVitaminovPRO ranked added it 7 months ago on Jun 18, 2019